Acknowledgments
The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: Cat#12535 3T3-msCD40L cells, from Dr. Mark Connors.
Disclosure statement
R.Mar. received research funding from Janssen and Gilead and honoraria from Gilead, Janssen, Abbvie, Roche and Shire. M.L received honoraria from Gilead, MSD, Pfizer. R.Maf. has received speaker fee from Abbvie.
Author contributions
R.Maf. conceived the research, coordinated the research, performed the statistical analyses and interpreted the results; R.Maf. and S.F. performed the in vitro experiments; S.F. acquired and analyzed flow cytometric data; C.G.A. performed some experiments during the revision phase of the manuscript; S.B performed molecular analyses; G.D. and P.Z. managed the biological samples; R.Maf supervised the work-flow and wrote the manuscript; R.Maf., S.F., L.P., M.L., and R.Mar. revised and approved the final version of the paper.